Weeks-long local pain relief after surgery
Raised to date
$45M
of $60M offered across 1 Form D filing
Allay Therapeutics is a pioneering company dedicated to transforming post-surgical pain management. By developing innovative solutions that extend localized pain relief for weeks, they aim to reduce opioid use, minimize addiction risks, and lower healthcare costs associated with traditional pain management.
Allay Therapeutics is distinguished by its advanced technology that provides prolonged, targeted pain relief, thereby reducing the necessity for opioids and enhancing the post-operative recovery experience.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Feb 10, 2025 | Equity | $45M/ $60M | Form D |
Pain management technology
A sophisticated therapeutic platform designed to deliver sustained post-surgical pain relief, significantly reducing the need for opioids and facilitating a smoother recovery process.
Built for
Healthcare facilities, including hospitals and surgical centers
